Search For "dr vikram sengupta"
Direct Biologics reveals successful outcomes from EXIT COVID-19 Phase II C
Updated : 4 years, 3 months ago IST
Austin [Texas], April 6 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC) derived extracellular vesicle (EV) platform technology, announces topline results from its first-in-human, multicenter, Phase II double-blind, placeb
Read More